Acute administration of Zn, Mg, and thiamine improves postpartum depression conditions in mice

Archives of Iranian Medicine

Volumn 15, Issue 5, 2012, Pages 306-311

  Nikseresht, Sara ^a   Etebary, Sahabeh ^b   Karimian, Morteza ^a   Nabavizadeh, Fatemeh ^a   Zarrindast, Mohammad Reza ^c   Sadeghipour, Hamid Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anxiety; Depression; Magnesium; Thiamine; Zinc

Indexed keywords

MAGNESIUM CHLORIDE; THIAMINE; ZINC CHLORIDE; MAGNESIUM; ZINC;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; DRUG EFFECT; DRUG SCREENING; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; MAZE TEST; MOUSE; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PUERPERAL DEPRESSION; PUERPERIUM; TOTAL ANTIOXIDANT CAPACITY; TREATMENT DURATION; ANIMAL; DEPRESSION; DISEASE MODEL; DRUG EFFECTS; HUMAN; MAJOR DEPRESSION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MAGNESIUM; MAZE LEARNING; MICE; THIAMINE; ZINC;

EID: 84872417175     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Skalkidou A, Sylvén SM, Papadopoulos FC, Olovsson M, Larsson A, Sundstrm-Poromaa I. Risk of postpartum depression in association with serum leptin and interleukin-6 levels at delivery: A nested case- control study within the UPPSAT cohort. Psychneuroendocrinology. 2009; 34: 1329-1337.
2. Steiner M, Dunn E, Born L. Hormones and mood: From menarche to menopause and beyond. J Afective Disord. 2003; 74: 67-83.
3. Green AD, Barr AM, Galea LAM. Role of estradiol withdrawal in 'anhedonic'sucrose consumption: A model of postpartum depression. Physiol Behav. 2009; 97: 259-265.
4. Klainin P, Arthur DG. Postpartum depression in Asian cultures: A literature review. Int J Nurs Stud. 2009; 46: 1355-1373.
5. Spinelli MG. Maternal infanticide associated with mental illness: Prevention and the promise of saved lives. Am J Psychiatry. 2004; 161: 1548-1557.
6. Beckley EH, Finn DA. Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility. Pharmacol, Biochem Behav. 2007; 87: 412-419.
7. Gulinello M, Gong QH, Smith SS. Progesterone withdrawal increases the anxiolytic actions of gaboxadol: Role of [alpha] 4 [beta][delta] GABAA receptors. Neuroreport. 2003; 14: 43.
8. Maguire J, Mody I. GABAAR plasticity during pregnancy: Relevance to postpartum depression. Neuron. 2008; 59: 207-213.
9. Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H. Magnesium-deficient diet alters depression-and anxiety-related behavior in mice-influence of desipramine and hypericum perforatum extract. Neuropharmacology. 2004; 47: 1189-1197.
10. Zonana J, Gorman JM. The neurobiology of postpartum depression. Int J Neuropsychiatric Med. 2005; 10: 792-799.
11. Bäckström T, Andersson A, Andree L, Birzniece V, Bixo M, Björn I, et al. Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci. 2003; 1007: 42-53.
12. Cardoso CC, Lobato KR, Binfaré RW, Ferreira PK, Rosa AO, Santos ARS, et al. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuro-Psycho- pharmacol Biol Psychiatry. 2009; 33: 235-242.
13. Groer MW, Morgan K. Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology. 2007; 32: 133-139.
14. Szewczyk B, Poleszak E, Wla P, Wrbel A, Blicharska E, Cichy A, et al. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009; 33: 323-329.
15. Nowak G, Szewczyk B, Pilc A. Zinc and depression: An update. Pharmacol Rep. 2005; 57: 713-718.
16. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res Rev. 2000; 34: 137-148.
17. Kroczka B, Branski P, Palucha A, Pilc A, Nowak G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull. 2001; 55: 297-300.
18. Nowak G, Szewczyk B, Wieronska JM, Branski P, Palucha A, Pilc A, et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull. 2003; 61: 159-164.
19. Takeda A, Tamano H, Kan F, Itoh H, Oku N. Anxiety-like behavior of young rats after 2-week zinc deprivation. Behav Brain Res. 2007; 177: 1-6.
20. Wjcik J, Dudek D, Schlegel-Zawadzka M, Grabowska M, Marcinek A, Florek E, et al. Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep. 2006; 58: 571-576.
21. Imada Y, Yoshioka S, Ueda T, Katayama S, Kuno Y, Kawahara R. Relationships between serum magnesium levels and clinical background factors in patients with mood disorders. Psychiatry Clin Neurosci. 2002; 56: 509-514.
22. Loyke HF. Effects of elements in human blood pressure control. Biol Trace Elem Res. 2002; 85: 193-209.
23. Poleszak E, Szewczyk B, Kdzierska E, Wla P, Pilc A, Nowak G. Antidepressant-and anxiolytic-like activity of magnesium in mice. Pharmacol, Biochem Behav. 2004; 78: 7-12.
24. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006; 67: 362-370.
25. Nakagawasai O, Murata A, Arai Y, Ohba A, Wakui K, Mitazaki S, et al. Enhanced head-twitch response to 5-HT-related agonists in thiaminedeficient mice. J Neural Transm. 2007; 114: 1003-1010.
26. Nakagawasai O, Yamadera F, Iwasaki K, Asao T, Tan-No K, Niijima F, et al. Preventive effect of kami-untan-to on performance in the forced swimming test in thiamine-deficient mice: Relationship to functions of catecholaminergic neurons. Behav Brain Res. 2007; 177: 315-321.
27. Cumurcu BE, Ozyurt H, Etikan I, Demir S, Karlidag R. Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment. Psychiatry Clin Neurosci. 2009; 63: 639-645.
28. Sarandol A, Sarandol E, Eker S, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: Short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol-Clin Exper. 2007; 22: 67-73.
29. Bloch M, Rotenberg N, Koren D, Klein E. Risk factors for early post-partum depressive symptoms. Gen Hosp Psychiatry. 2006; 28: 3-8.
30. Bhatia SC, Bhatia SK. Depression in women: Diagnostic and treatment considerations. Am Fam Physician. 1999; 60: 225-234.
31. Pearlstein T. Perinatal depression: Treatment options and dilemmas. J Psychiatry Neurosci. 2008; 33: 301-318.
32. Dennis CL, Chung-Lee L. Postpartum depression help-seeking barriers and maternal treatment preferences: A qualitative systematic review. Birth. 2006; 33: 323-331.
33. Lobato KR, Binfaré RW, Budni J, Rosa AO, Santos ARS, Rodrigues ALS. Involvement of the adenosine A1 and A2A receptors in the anti-depressant-like effect of zinc in the forced swimming test. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008; 32: 994-999.
34. Nakagawasai O, Tadano T, Hozumi S, Taniguchi R, Tan-No K, Esashi A, et al. Characteristics of depressive behavior induced by feeding thiamine-deficient diet in mice. Life Sci. 2001; 69: 1181-1191.
35. Kaster MP, Ferreira PK, Santos ARS, Rodrigues ALS. Effects of potassium channel inhibitors in the forced swimming test: Possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res. 2005; 165: 204-209.
36. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 1987; 92: 180-185.
37. Zarrindast MR, Homayoun H, Babaie A, Etminani A, Gharib B. Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. Eur J Pharmacol. 2000; 407: 145-158.
38. Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol. 2008; 18: 323-332.
39. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice:Aa primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977; 229: 327.
40. Miller N, Rice-Evans C, Davies M, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 1993; 84: 407-412.
41. Ramanathan B, Jan KY, Chen CH, Hour TC, Yu HJ, Pu YS. Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res. 2005; 65: 8455.
42. Stoffel EC, Craft RM. Ovarian hormone withdrawal-induced "depression" in female rats. Physiol Behav. 2004; 83: 505-513.
43. Bitran D, Smith SS. Termination of pseudopregnancy in the rat produces an anxiogenic-like response that is associated with an increase in benzodiazepine receptor binding density and a decrease in GABA- stimulated chloride influx in the hippocampus. Brain Res Bull. 2005; 64: 511-518.
44. Rosa AO, Lin J, Calixto JB, Santos ARS, Rodrigues ALS. Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. J Affective Disord. 2003; 144: 87-93.
45. Nahar Z, Azad MAK, Rahman MA, Rahman MA, Bari W, Islam SN, et al. Comparative analysis of serum manganese, zinc, calcium, copper and magnesium level in panic disorder patients. Biol Trace Elem Res. 2009; 133: 1-7.
46. Cieslik K, Klenk-Majewska B, Danilczuk Z, Wrbel A, Lupina T, Ossowska G. Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep. 2007; 59: 46-52.
47. Cunha MP, Machado DG, Bettio LEB, Capra JC, Rodrigues ALS. Interaction of zinc with antidepressants in the tail suspension test. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008; 32: 1913-1920.
48. Frederickson CJ, Koh JY, Bush AI. The neurobiology of zinc in health and disease. Nat Rev Neurosci. 2005; 6: 449-462.
49. Fujimori K, Ishida T, Yamada J, Sato A. The effect of magnesium sulfate on the behavioral activities of fetal goats. Obstet Gynecol. 2004; 103: 137.
50. Ghasemi M, Montaser-Kouhsari L, Shafaroodi H, Nezami BG, Ebrahimi F, Dehpour AR. NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test. Psychopharmacology. 2009; 206: 325-333.
51. Sadeghipour HR, Ghasemi M, Sadeghipour H, Riazi K, Soufiabadi M, Fallahi N, et al. Nitric oxide involvement in estrous cycle-dependent changes of the behavioral responses of female rats in the elevated plusmaze test. Behav Brain Res. 2007; 178: 10-17.
52. Rodríguez-Landa JF, Contreras CM, García-Ríos RI. Allopregnanolone microinjected into the lateral septum or dorsal hippocampus reduces immobility in the forced swim test: Participation of the GABAA receptor. Behav Pharmacol. 2009; 20: 614.
53. Koklu E, Akcakus M, Narin F, Saraymen R. The relationship between birth weight, oxidative stress and bone mineral status in newborn infants. J Paediatr Child Health. 2007; 43: 667-672.
54. Toy H, Camuzcuoglu H, Arioz DT, Kurt S, Celik H, Aksoy N. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants. J Obstet Gynecol Res. 2009; 35: 1047-1053.
55. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: The potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 2003; 8: 365-370.
56. Duvan CI, Cumaoglu A, Turhan NO, Karasu C, Kafali H. Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet. 2010; DOI:10.1007/s00404-009-1347-y.
57. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004; 37: 277-285.
58. Galecki P, Szemraj J, Bienkiewicz M, Zboralski K, Gaecka E. Oxidative stress parameters after combined FLuoxetine and acetylsalicylic acid therapy in depressive patients. Hum Psychopharmacol Clin Exp. 2009; 24: 277-286.
59. Sofic E, Rustembegovic A, Kroyer G, Cao G. Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm. 2002; 109: 711-719.
60. Kamper EF, Chatzigeorgiou A, Tsimpoukidi O, Kamper M, Dalla C, Pitychoutis P, et al. Sex differences in oxidant/antioxidant balance under a chronic mild stress regime. Physiol Behav. 2009; 98: 215-222.